Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?-Reference-Cited by-同舟云学术

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

Published:2009-02-15 Issue:4 Volume:124 Page:919-923
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

van der Velde Nienke M.,Mourits Marian J.E.,Arts Henriëtte J.G.,de Vries Jacob,Leegte Beike K.,Dijkhuis Grieteke,Oosterwijk Jan C.,de Bock Geertruida H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Miki;Science,1994

2. Identification of the breast cancer susceptibility gene BRCA2;Wooster;Nature,1995

3. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews;Struewing;N Engl J Med,1997

4. The genetic attributable risk of breast and ovarian cancer;Claus;Cancer,1996

5. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J Clin Oncol,2007

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation;Journal of Gynecologic Oncology;2025

2. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers;Gynecologic Oncology;2024-08

3. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review;Cancer Medicine;2024-07

4. CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal study;2024-05-31

5. Reliability, costs, and radiation dose of dual-energy X-ray absorptiometry in diagnosis of radiologic sarcopenia in surgically menopausal women;Insights into Imaging;2024-04-08